Skip to content
NASDAQ · CHEMICALS & ALLIED PRODUCTS · LARGE CAP

Innospec Inc. IOSP

17 fiscal years on record · USD · FY2025 reported · SEC filings only
12 YEARS OF DIVIDEND GROWTH
$1.8B
▼ 3.7% YoY
$116.6M
▲ 227.5% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Innospec develops, manufactures, blends, markets and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The company employs approximately 2,450 people across 22 countries. It reports its financial performance based on three reportable segments: Performance Chemicals, Fuel Specialties and Oilfield Services.

Written from the business description in INNOSPEC INC.'s annual report to the U.S. Securities and Exchange Commission, filed 18 February 2026. Every sentence was checked against that document before publication.

Growth

USD 1.8B
Revenue, FY2025 · full 17-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.8 · Net income 0.1
1B2B
2009201220152018202120242025
Compound annual growth
−3.3%
+8.3%
+5.8%
+6.6%
−4.3%
+32.4%
−0.2%
−4.3%
+32.1%
−0.4%
+3.1%
+10.1%
+10.5%
+10.9%
+20.8%
+19.1%
+8.5%
+24.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +8.3% a year over the five years to FY2025 — but profit grew faster: net income at +32.4%, earnings per share at +32.1%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

7 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 7.3% · Net 6.6%
5%10%15%
200920172025
ROE
FY2025 · ROE 9.2%
10%20%30%
200920172025
Three returns, three denominators.

Each USD of equity produced 9 cents of profit this year.

Cash & shareholders

USD 66.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2015 · FCF 100.6
50M100M
200920172025
Net buybacks $M Dividends $M
FY2025 · Dividends 42.4 · Net buybacks 23.9
25.0M50.0MDividendsNet buybacks
200920112013201520172019202120232025

USD 42.4M in dividends and USD 23.9M in buybacks — 57% of the year's profit went back to shareholders.

Total assetsUSD 1.8B
EquityUSD 1.3B
CashUSD 292.5M
Current ratio2.79×

Equity funds 72% of total assets.

The 17-year record

17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
IOSP, 17-year financial record
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B1.81.81.92.01.51.21.51.51.30.91.01.00.80.80.80.70.6
Operating income $B0.10.20.20.20.10.00.10.10.10.10.20.10.10.10.00.10.0
EBITDA $B0.20.20.20.20.20.10.20.20.20.10.20.10.10.10.10.10.0
Income tax $B0.00.00.00.10.00.00.00.00.10.00.00.00.00.00.00.00.0
Net income $B0.10.00.10.10.10.00.10.10.10.10.10.10.10.10.00.10.0
Free cash flow $B◌◌◌◌◌◌◌◌◌◌0.10.10.10.10.00.00.1
EPS, diluted $4.671.425.565.323.751.164.543.452.523.334.863.383.222.811.922.970.26
Dividend / sh $1.711.551.411.281.161.041.020.890.770.670.610.550.502.000.000.000.05
Payout %361092524318922263020121615700019
ROE %9.23.012.712.89.43.112.910.58.512.921.318.221.420.314.632.24.1

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 83 reconciliationsAUDITED

Reconciled in 17 of the 17 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Two checks were skipped: EPS is not tagged before 2009. Two checks were skipped: revenue is not tagged before 2009.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityChemicals & Allied Products
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2009

Share this section

Download image